MHRA approves Retifanlimab (ZYNYZ) for the treatment of advanced Merkel cell skin cancer

Merkel cell carcinoma (MCC) is a rare and aggressive type of skin cancer that develops from Merkel cells, specialised neuroendocrine cells found in the top layer of the skin.